Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to LUNG CANCER

Cancer Therapy Advisor

ASCO Updates Guidelines for Stage IV NSCLC

Medical Oncology March 31st 2025

Oncology News Central (ONC)

FDA Rejects Application for Subcutaneous Amivantamab in Non-Small Cell Lung Cancer

Medical Oncology January 7th 2025

Oncology News Central (ONC)

Big Year in SCLC: “Unprecedented” Results Lead to New Standard of Care

Medical Oncology December 3rd 2024

Cancer Therapy Advisor

Lung Cancer and AI: The Time Has Come Today

Medical Oncology October 8th 2024

Oncology News Central (ONC)

What “Incredibly Dramatic” Data on Osimertinib in NSCLC Mean for Practice

Medical Oncology September 9th 2024

Oncology News Central (ONC)

FDA’s ODAC Votes for New Requirements Due to Overtreatment Concerns in NSCLC

Medical Oncology August 12th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form